The screening with the liquid biopsy for the rechallenge with anti-epidermal growth factor receptor antibodies in metastatic colorectal cancer A perspective based on pharmacological costs

Recenti Prog Med. 2023 Sep;114(9):563-564. doi: 10.1701/4088.40818.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents*
  • Cetuximab
  • Colonic Neoplasms*
  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / drug therapy
  • Early Detection of Cancer
  • Humans
  • Liquid Biopsy
  • Receptors, Growth Factor / therapeutic use

Substances

  • Cetuximab
  • Receptors, Growth Factor
  • Antineoplastic Agents